Table 2 Description of Breast Cancer Patients
From: Oligoclonality of CD8+ T Cells in Breast Cancer Patients
Patients | Age | Primary tumor | Positive nodes | HLA haplotype | Specimen | ||
|---|---|---|---|---|---|---|---|
A | B | C | |||||
S.G. | 39 | Noninvasive, ductal | 0 | LN, PBL | |||
D.C. | 47 | Microinvasive, ductal | 0 | LN, PBL | |||
E.H. | 61 | Microinvasive, ductal | 0 | LN, PBL | |||
B.F. | 45 | Microinvasive, ductal | 0 | LN, PBL | |||
G.L. | 60 | Microinvasive, lobular | 0 | PBL | |||
D.M. | 63 | Invasive, ductal | 0 | 2,3 | 18,53 | 4,7 | LN, PBL |
M.T. | 76 | Invasive, ductal | 0 | 26,30 | 18,38 | 5.8 | LN, PBL |
C.D. | 56 | Invasive, medullary | 0 | 2,11 | 45,50 | 6,7 | LN |
M.B. | 56 | Invasive, lobular | 0 | 2,26 | 44,50 | 6,7 | LN |
I.L. | 66 | Invasive, ductal | 0 | LN | |||
D.D. | 40 | Invasive, lobular | 0 | 1,25 | 8,37 | 7,— | LN |
V.V. | 55 | Invasive, ductal, lobular | 0 | LN | |||
J.W. | 59 | Invasive, ductal | 0 | LN | |||
J.K. | 65 | Invasive, ductal | 0 | LN | |||
M.Z. | 58 | Invasive, cystosarcoma phylloides | 0 | PBL | |||
P.V. | 40 | Invasive, medullary | 2/23 | 24,30 | 44,52 | 4,7 | LN, PBL |
H.E. | 72 | Invasive, ductal | 8/19 | 2,24 | 39,57 | 6,7 | LN |
H.H. | 69 | Invasive, lobular | 23/39 | 2,23 | 44,50 | 5,6 | LN |
I.D. | 70 | Invasive, ductal | 6/19 | PBL | |||
J.P. | 49 | Invasive, ductal | 22/22 | PBL | |||